ArriVent BioPharma, Inc. — SCHEDULE 13G/A Filings
9 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by ArriVent BioPharma, Inc. (AVBP), sorted by most recent first. Each row links to the full filing on EdgarLookup. ArriVent BioPharma, Inc. has filed 9 SCHEDULE 13G/A documents with the SEC since 2021. To view all SEC filings by ArriVent BioPharma, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001104659-26-023750 | Mar 5, 2026 | — |
| SCHEDULE 13G/A | — | 0002058093-26-000004 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-001013 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000102909-26-000090 | Jan 30, 2026 | — |
| SCHEDULE 13G/A | — | 0001214659-25-016716 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002677 | Nov 5, 2025 | — |
| SCHEDULE 13G/A | — | 0002012383-25-002500 | Oct 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-021943 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000919574-25-004712 | Aug 13, 2025 | — |